NAS:DNLI (USA) Also trade in: Germany

Denali Therapeutics Inc

$ 19.63 0 (0%)
Volume: 370,430 Avg Vol (1m): 381,177
Market Cap $: 1.87 Bil Enterprise Value $: 1.39 Bil
P/E (TTM): 0.00 P/B: 3.61
Earnings Power Value 0
Net Current Asset Value 3.58
Tangible Book 5.44
Projected FCF 0
Median P/S Value 656.48
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)
Shares Outstanding
82.74 (Mil)
Institutional Ownership
3.50 (Mil)
Insider Ownership
44.36 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Denali Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.

Insider ownership (%)

This is the historical insider ownership of Denali Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders